In the current study, patients with severe inflammation or hyperparathyroidism were not included (the mean hCRP and int-PTH levels were 0.29±1.23 mg/dL and 148 ± 121 pg/mL, respectively), which may explain the discrepancy between this study and previous studies. The gene discussed is PTH; the disease is hyperparathyroidism.